Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Infection

• Publication date

  1986-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0163-4453(86)92608-3PMID 2943811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization.

  1985cited by this paper
• Human hepatitis B vaccine from recombinant yeast

  1984cited by this paper
• Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.

  1984cited by this paper
• PREVENTION OF THE HBsAg CARRIER STATE IN NEWBORN INFANTS OF MOTHERS WHO ARE CHRONIC CARRIERS OF HBsAg AND HBeAg BY ADMINISTRATION OF HEPATITIS-B VACCINE AND HEPATITIS-B IMMUNOGLOBULIN: Double-blind Randomised Placebo-controlled study

  1984cited by this paper
• Hepatitis B vaccine: evidence confirming lack of AIDS transmission.

  1984cited by this paper
• Who should be immunised against hepatitis B?

  1984cited by this paper
• Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA.

  1984cited by this paper
• Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.

  1983cited by this paper
• Mechanisms of maternal-fetal transmission of hepatitis B virus.

  1978cited by this paper
• THE SIMIAN CREASE.

  1964cited by this paper

• Combating Vaccine Disinformation: The Professional Responsibilities of Pediatric Nurse Practitioners.

  2026cites this paper
• An Evidence-based Practical Guide to Vaccination for Hepatitis B Virus

  2022cites this paper
• Vaccines for immunoprevention of cancer.

  2021cites this paper
• Hepatitis B vaccine development and implementation

  2020cites this paper
• Household survey of hepatitis B vaccine coverage among Brazilian children.

  2009cites this paper
• Cochrane review: Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers

  2007cites this paper
• Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis

  2006cites this paper
• Hepatitis B immunisation for newborn infants of hepatitis B surface antigen‐positive mothers

  2006cites this paper
• meta-analysisantigen: systematic review and infants of mothers positive for hepatitis B Effect of hepatitis B immunisation in newborn

  2006cites this paper
• Impact of hepatitis B immunization, Europe and worldwide.

  2003cites this paper
• IMPACT OF HEPATITIS B IMMUNIZATION, EUROPE AND WORLDWIDE

  2003cites this paper
• Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).

  1998cites this paper
• Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System.

  1996cites this paper
• Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies.

  1993cites this paper
• Vaccines against hepatitis A and B

  1993cites this paper
• An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.

  1992cites this paper
• Hepatitis B vaccines: blueprints for vaccines of the future.

  1992cites this paper
• Perinatal transmission of hepatitis B virus infection: a recommended strategy for prevention and control. A Review

  1991cites this paper
• Comparative evaluation of the immunogenicity of yeast‐derived (recombinant) and plasma‐derived hepatitis B vaccine in infants

  1991cites this paper
• Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.

  1989cites this paper
• Lack of induction of IgE and IgG antibodies to yeast in humans immunized with recombinant hepatitis B vaccines.

  1988cites this paper
• Hepatitis B and AIDS and the promise for their control by vaccines.

  1988cites this paper
• Immunogenicity of a recombinant DNA hepatitis B vaccine in neonates.

  1987cites this paper
• Use of the hepatitis B recombinant DNA yeast vaccine (H-B-VAX II) in children: Two doses vs. three doses of 5 μg regime; an interim report

  1986cites this paper
• Use of the hepatitis B recombinant DNA yeast vaccine (H-B-VAX II) in children: two doses vs. three doses of 5 micrograms regime; an interim report.

  1986cites this paper